Keenova Therapeutics and Par Health
The Manufacturing Associate at Par Health processes active compound materials into final tablet form and ensures products meet manufacturing specifications. The role supports production operations and quality initiatives while maintaining accurate and compliant documentation. The position emphasizes adherence to cGMP, SOPs, environmental health and safety guidelines, and participation in continuous improvement activities.
Keenova Therapeutics and Par Health are the successor entities formed after Mallinckrodt's merger with Endo; Keenova Therapeutics focuses on specialty therapeutics across rare and unaddressed conditions (immunology, urology, hepatology, ophthalmology, orthopedics, critical care), while Par Health develops high-quality generics, sterile injectables, and active pharmaceutical ingredients (APIs) with a robust U.S.-advantaged manufacturing network.
Mallinckrodt, Endo Complete Merger to Create Global, Scaled, Diversified Therapeutics Leader
Aug 1, 2025
With merger in the books, Mallinckrodt and Endo rebrand as Keenova and spin off Par Health
Nov 11, 2025
Judge Says 'Error' Kept Mallinckrodt Execs In Investor Suit
2 weeks ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Keenova Therapeutics and Par Health.
Mallinckrodt Names Christiana Stamoulis President and CFO
Aug 6, 2025
Manufacturing Technician I
Takeda Pharmaceutical Company Limited
QA Inspector II - 2nd Shift
lifelancer
Environmental Monitoring Technician I
Alcami Corporation
Manufacturing Technician
Kedrion Biopharma
Manufacturing Equipment Operator - C Shift- BFS
Unither Pharmaceuticals
Manufacturing Process Operations
oraclecloudinfrastructure